China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 | -127.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -161.95% |
| Dec 31, 2025 | -127.65% |
| Sep 30, 2025 | 94.11% |
| Jun 30, 2025 | 52.83% |
| Mar 31, 2025 | 32.26% |
| Dec 31, 2024 | 5,790.60% |
| Sep 30, 2024 | -157,419.40% |
| Jun 30, 2024 | -1,984.23% |
| Mar 31, 2024 | -698.56% |
| Dec 31, 2023 | 120.56% |
| Sep 30, 2023 | 99.90% |
| Jun 30, 2023 | -187.96% |
| Mar 31, 2023 | -19.76% |
| Dec 31, 2022 | -275.28% |
| Sep 30, 2022 | -127,837.18% |
| Jun 30, 2022 | 14,270.61% |
| Mar 31, 2022 | -16,492.70% |
| Dec 31, 2021 | 42.10% |
| Sep 30, 2021 | 10.88% |
| Jun 30, 2021 | -1,180.03% |